Variable Association between Components of the Metabolic Syndrome and Electrocardiographic Abnormalities in Korean Adults by Kim, Hong-Kyu et al.
Variable Association between Components of the Metabolic
Syndrome and Electrocardiographic Abnormalities in Korean
Adults
Hong-Kyu Kim
1, Chul-Hee Kim
2, Kwan-Ho Ko
1, Seong-Wook Park
3, Joong-Yeol Park
4, and Ki-Up Lee
4
1Health Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 2Division of Endocrinology &
Metabolism, Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon; Divisions of 3Cardiology,
4Endocrinology & Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea
DOI: 10.3904/kjim.2010.25.2.174
ORIGINAL ARTICLE
Background/Aims: Resting electrocardiogram (ECG) abnormalities have been strongly associated with
cardiovascular disease mortality. Little is known, however, about the association between individual components
of metabolic syndrome and ECG abnormalities, especially in Asian populations. 
Methods: We examined clinical and laboratory data from 31,399 subjects (age 20 to 89 years) who underwent
medical check-ups. ECG abnormalities were divided into minor and major abnormalities based on Novacode
criteria. Ischemic ECG findings were separately identified and analyzed. 
Results: The overall prevalence rates of ECG abnormalities were significantly higher in subjects with than in
those without metabolic syndrome (p < 0.01). Ischemic ECG was strongly associated with metabolic syndrome in
all age groups of both sexes, except for younger women. In multiple logistic regression analysis, metabolic
syndrome was independently associated with ischemic ECG (odds ratio, 2.30 [2.04 to 2.62]; p < 0.01), after
adjusting for sex, age, smoking, and family history of cardiovascular disease. Of the metabolic syndrome
components, hyperglycemia in younger subjects and hypertension in elderly subjects were major factors for
ischemic ECG changes, whereas hypertriglyceridemia was not an independent risk factor in any age group. The
association between ischemic ECG findings and central obesity was weaker in women than in men. 
Conclusions: Metabolic syndrome was strongly associated with ECG abnormalities, especially ischemic ECG
findings, in Koreans. The association between each component of metabolic syndrome and ECG abnormalities
varied according to age and sex. (Korean J Intern Med 2010;25:174-180)
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INTRODUCTION
Metabolic syndrome refers to a constellation of ischemic
heart disease risk factors, including central obesity,
disorders of glucose and lipid metabolism, and hyper-
tension, each of which has been shown individually to
increase cardiovascular risk [1-6]. Furthermore, metabolic
syndrome itself has been shown to increase cardiovascular
and all-cause mortality in subjects without known heart
disease [7-9]. Although the association between metabolic
syndrome and cardiovascular disease (CVD) is well
established, the magnitude of the association is highly
variable according to the age, sex, and ethnicity of the
study population.   
Resting electrocardiogram (ECG) abnormalities have
been strongly associated with subsequent all cause,
coronary heart disease (CHD), and CVD mortality [10-
13]. For example, the severity of abnormal ECG findings,Kim HK, et al. Metabolic syndrome and ECG abnormalities    175
defined as minor and major abnormalities by Novacode
criteria, has been correlated with increasing risk for CHD
events and mortality [13]. During recent decades, the
rapid economic growth and lifestyle changes in many
Asian countries, including South Korea, have led to
increases in CVD and metabolic syndrome. Little is
known, however, about the association between metabolic
syndrome and ECG abnormalities, especially in Asian
populations [14,15]. Moreover, variability in the association
between each component of metabolic syndrome and
ECG abnormalities has not been clarified. We therefore
investigated the association between ECG abnormalities
and metabolic syndrome in Korean adults. We also
assessed the relationship between ECG abnormalities
and individual metabolic syndrome components according
to age and sex. 
METHODS
Subjects
We examined clinical and laboratory data from 31,399
subjects (18,717 men and 12,682 women; median age, 48
years [range, 20 to 89]) who visited the Health Promotion
Center at Asan Medical Center for medical check-ups in
2006. Each participant was administered a standard
questionnaire that assessed alcohol intake, smoking
habits, usual patterns of physical activity, medical history,
family history of diabetes and ischemic heart disease,
and regular medication. This study was approved by the
Institutional Review Board of the Asan Medical Center.
Measurements
Height and weight were measured while subjects were
wearing light clothing without shoes. Waist circumference
was measured midway between the costal margin and the
iliac crest at the end of a normal expiration. Blood pressure
was measured with a mercury sphygmomanometer on the
right arm with subjects in the sitting position after a 5
minutes rest. Body mass index (BMI) was calculated as
weight in kilograms divided by the square of height in
meters. Blood samples were obtained in the morning after
an overnight fast. Plasma glucose was measured by the
hexokinase method using an autoanalyzer (Hitachi,
Tokyo, Japan). Standard liver function testing, total
cholesterol, high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol, and triglycerides
were also measured using an autoanalyzer (Hitachi). 
Definition of metabolic syndrome
Metabolic syndrome was diagnosed using the 2005
revised National Cholesterol Education Program - Adult
Treatment Panel III (NCEP-ATP III) criteria [16] with the
Asian specific cutoff point for abdominal obesity [17].
According to these criteria, subjects with metabolic
syndrome are those with any combination of three or
more of the following risk determinants: fasting plasma
glucose ≥ 5.6 mmol/L or on antidiabetic treatment, blood
pressure ≥ 130 / 85 mmHg or on antihypertensive treatment,
plasma triglycerides ≥ 1.7 mmol/L, plasma HDL
cholesterol < 1.03 mmol/L in men and < 1.29 mmol/L in
women, and waist circumference > 90 cm in men and > 80
cm in women.
ECG analysis
Standard 12-lead ECGs were recorded with each
subject in the supine position using strictly standardized
procedures. Special attention was paid to locating the
chest electrodes at precise positions [18]. All ECGs were
inspected visually to detect technical errors, missing leads,
and inadequate quality. ECGs were coded by a cardiology
specialist using the Novacode system [19].
ECG abnormalities were divided into minor and major
abnormalities based on Novacode criteria [19]. Minor
ECG abnormalities included any of the following: 1) first-
and second-degree atrioventricular block (Novacode 2.1
and 2.2.1); 2) borderline prolonged ventricular excitation
(Novacode 3.4.1 and 3.4.2); 3) prolonged ventricular
repolarization (Novacode 4.1.1 and 4.1.2); 4) isolated
minor Q and ST-T abnormalities (Novacode 5.7 and 5.8);
5) left ventricular hypertrophy without ST-T abnormalities
(Novacode 6.1.0); 6) left atrial enlargement (Novacode
7.1); 7) frequent atrial or ventricular premature beats
(Minnesota code 8.1); and 8) fascicular blocks (Novacode
10.1 and 10.2).  Major ECG abnormalities included any of
the following: 1) atrial fibrillation or atrial flutter
(Novacode 1.5); 2) high-degree atrioventricular dissociation
(Novacode 2.3.1 and 2.3.2); 3) left bundle-branch block
(Novacode 3.1.0 and 3.1.1); 4) right bundle-branch block
(Novacode 3.2.0); 5) indeterminate conduction delay
(Novacode 3.3.0 and 3.3.1); 6) Q-wave myocardial
infarction (MI) (Novacode 5.1, 5.2, 5.3, and 5.4); 7)
isolated ischemic abnormalities (Novacode 5.5 and 5.6);
8) left ventricular hypertrophy with ST-T abnormalities
(Novacode 6.1.1); and 9) miscellaneous arrhythmias (e.g.,
supraventricular tachycardia, ventricular preexcitation,
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2.4). 
‘Ischemic ECG’ findings (signs suggesting MI or
ischemia) were defined as the presence of Q/Qs patterns,
significant or borderline ST segment depression, deep or
moderate T wave inversion, or evidence of complete left
bundle-branch block [20]. ‘Non-ischemic ECG abnormalities’
were defined as all other minor or major ECG abnormalities.
Statistics
Data are expressed as means ± SD. Variables not normally
distributed, such as blood concentrations of glucose and
triglycerides, were log-transformed before analysis. A chi-
square (χ2) test was used to compare prevalence rates of
ECG abnormalities between groups with and without the
metabolic syndrome. Logistic regression analyses were
used to find independent factors for ischemic ECG and to
obtain odds ratio after adjusting for several clinical and
biochemical variables. Statistical analyses were performed
using the SPSS version 14.0 (SPSS Inc., Chicago, IL, USA).
A p value of less than 0.05 was considered statistically
significant.
RESULTS
The clinical and laboratory characteristics of the study
subjects are listed in Table 1. Of the 31,399 subjects, 5,226
(17%) had metabolic syndrome (20% for men and 13% for
women), defined by modified ATP III criteria with Asia-
Pacific guidelines for waist circumference. Using the
original ATP III waist circumference criteria (102 cm in
men and 88 cm in women), the prevalence of metabolic
syndrome was 12% (13% for men and 11% for women).
Table 2 lists the prevalence of metabolic syndrome
according to sex and age. The prevalence of metabolic
syndrome in subjects > 60 years old was markedly higher
(26% in men and 38% in women) than in younger age
(< 60 years) groups, especially in women.
According to the Novacode criteria, 4% (6% of men, 3%
of women) of the subjects had major ECG abnormalities,
and 16% (19% of men, 12% of women) had minor abnor-
malities. Both major and minor ECG abnormalities were
more prevalent in subjects with metabolic syndrome than
in those without (p < 0.01 each by χ2 test) (Table 3).
Ischemic ECG abnormalities were identified in 4% of the
subjects (4% of men, 5% of women), and non-ischemic
ECG abnormalities in 17% (21% of men, 11% of women).
The prevalence rates of ischemic (9% vs. 4%, p < 0.01 by
χ2 test) and non-ischemic ECG (20% vs. 16%, p < 0.01 by
χ2 test) abnormalities were significantly higher in subjects
with metabolic syndrome. Ischemic ECGs showed a
strong association with metabolic syndrome in all age
groups of both sexes, except for women < 40 years old
Table 1. Clinical and laboratory characteristics of the
subjects 
Characteristics Men Women
(n = 18,717) (n = 12,682)
Age, yr 48 ± 10 47 ± 10
Glucose, mmol/L 5.4 ± 1.1 5.2 ± 0.9
Triglycerides, mmol/L 1.64 ± 1.03 1.15 ± 0.71
Total cholesterol, mmol/L 4.91 ± 0.85 4.86 ± 0.88
HDL-cholesterol, mmol/L 1.37 ± 0.31 1.60 ± 0.39
Waist circumference, cm 83 ± 9 80 ± 8
BMI, kg/m2 24.5 ± 2.7 22.8 ± 3.0
SBP, mmHg 121 ± 14 113 ± 16
DBP, mmHg 76 ± 9 71 ± 9
History of DM, % 5 3
History of hypertension, % 16 12
Smoking, % 38 4
Values are presented as mean ± SD.
HDL, high-density lipoprotein; BMI, body mass index; SBP,
systolic blood pressure; DBP, diastolic blood pressure; DM,
diabetes mellitus.
Table 2. Prevalence of metabolic syndromea according to age and sex
Age groups, yr Metabolic syndrome  
Total Men Women
All age groups 5,226 / 31,399 (17) 3,641 / 18,717 (20) 1,585 / 12,682 (13)
20 - 39 505 / 6,197 (8) 438 / 3,396 (13) 67 / 2,801 (2)
40 - 59 3,547 / 21,402 (17) 2,618 / 13,067 (20) 929 / 8,335 (11)
Over 60 1,174 / 3,800 (31) 585 / 2,254 (26) 589 / 1,546 (38)
Values are presented as number / total number (%).
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(Table 4).
In a multiple logistic regression analysis, metabolic
syndrome was independently associated with ischemic
ECG (odds ratio [OR], 2.30; 95% confidence interval, 2.04
to 2.62, p< 0.01) after adjusting for sex, age, smoking, and
family history of CHD (Table 5). We also used multiple
logistic regression analyses to calculate the OR for each
component of the metabolic syndrome in different sex and
age groups (Table 6). Among the various components of
metabolic syndrome, hyperglycemia and central obesity in
men < 40 years old and hyperglycemia in women < 40
years old were main risk determinants for ischemic ECG,
Table 5. Adjusted odds ratios for factors associated with ischemic ECG, as determined by multiple logistic
regression analysis
Odds ratios 95% Confidence interval p value
Metabolic syndrome 2.30 2.04 - 2.62 < 0.01
Sex (male) 0.64 0.55 - 0.77 < 0.01
Age group, yr 20 - 39 1 (as reference)
40 - 59 1.74 1.44 - 2.11 < 0.01
Over 60  4.00 3.23 - 4.96 < 0.01
Smoking Never smoked 1 (as reference)
Ex-smoker 0.94 0.78 - 1.14 NS
Current smoker 0.98 0.82 - 1.18 NS
Family history of CHD 0.98 0.80 - 1.19 NS
ECG, electrocardiogram; CHD, coronary heart disease; NS, not significant.
Table 3. Prevalence of major and minor ECG abnormalities by Novacode criteria in subjects with or without
metabolic syndrome
ECG findings Metabolic syndrome
Without With
Total Men Women Total  Men Women
Normal ECG 20,972 (81) 11,490 (77) 9,482 (86) 3,719 (71) 2,586 (71) 1,133 (72)
Minor abnormality 4,009 (15) 2,827 (19) 1,182 (11) 1,074 (21)a 751 (21) 323 (20)a
Major abnormality 988 (4) 680 (5) 308 (3) 416 (8)a 296 (8)a 120 (8)a
Values are presented as number (%).
ECG, electrocardiogram.
ap < 0.01 vs. subjects without metabolic syndrome by χ2 test.
Table 4. Prevalence of ischemic ECGs according to age, sex, and metabolic syndrome
Age, yr Men Women
Metabolic syndrome Metabolic syndrome 
Without With Without With
All age groups 446 / 15,074 (3) 258 / 3,641 (7) 484 / 11,093 (4) 198 / 1,585 (13)
20 - 39 52 / 2,957 (2) 22 / 438 (5)a 57 / 2,732 (2) 2 / 67 (3)
40 - 59 294 / 10,448 (3) 175 / 2,618 (7)a 313 / 7,404 (4) 94 / 929 (10)a
Over 60 100 / 1,669 (6) 61 / 585 (10)a 114 / 957 (12) 102 / 589 (17)a
Values are presented as number / total number (%).
ECG, electrocardiogram.
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whereas hypertension and low HDL cholesterol in men >
60 years old and hypertension in women > 60 years old
were additional risk factors for ischemic ECG. Elevated
triglyceride level was not an independent risk factor for
ischemic ECG in any subgroup. Low HDL cholesterol was
also not a significant risk factor in women. In addition, the
association of ischemic ECG findings with central obesity
was much weaker in women than in men, especially in
younger age groups.  
DISCUSSION
In this cross-sectional study of a large number of Korean
subjects, we showed that metabolic syndrome was strongly
associated with ECG abnormalities, especially ischemic
ECG findings, in a Korean population. This association
was independent of other important risk factors for
coronary artery disease, including subject age, smoking
history, and family history of CHD. These results are
consistent with previous findings in other populations, i.e.,
that metabolic syndrome is associated with an increased
risk of cardiovascular morbidity and mortality [8,21-23]. 
A unique finding of this study is that the association
between ischemic ECG and each component of metabolic
syndrome varied significantly according to age and sex.
We found that hyperglycemia was the main risk deter-
minant for ischemic ECG findings in younger (< 40 years
old) subjects, whereas hypertension was important in
older groups. In contrast, hypertriglyceridemia was not
an independent risk factor in any age group, a finding
consistent with a recent report showing that elevated
triglyceride levels are not associated with 10-year CVD risk
in a middle-aged Chinese population [24]. We also found
that the association between ischemic ECG changes and
central obesity was weaker in women than in men, especially
in younger women. It was suggested that the waist
circumference criterion for diagnosing metabolic syndrome
may be too strict for Asian women [25]. The optimal cut-
off value of waist circumference for Asian women should
therefore be determined by long-term prospective
population-based studies.
Using the Asia-Pacific criteria for waist circumference,
the overall prevalence of metabolic syndrome in our study
subjects was 17%, which is lower than that in the US (24%
in men, 23% in women) [26], but similar to findings in
other Korean [27] and Chinese [25] populations. In
addition, the prevalence of ischemic ECG abnormalities in
our study population (4% for men, 5% for women) was
lower than in Iranian [14] and Belgian [20] populations (8
to 10% for men, 10 to 15% for women). The latter difference
may be due to differences in ethnicity, age distribution,
and / or lifestyle of the study subjects. Consistent with the
concept that metabolic syndrome is a marker of cardio-
vascular risk, the prevalence of metabolic syndrome was
correlated with that of ischemic ECG abnormalities.
Interestingly, we found that the prevalence of metabolic
syndrome was much higher in elderly (> 60 years) women
(38%) than in elderly men (26%), a finding consistent
with previous results in Korean [27,28] and Chinese
[25,29] populations, but different from findings in a US
population [26] that reported similar prevalences in
elderly men and women. Moreover, the prevalence of
ischemic ECG abnormalities was higher in elderly women
(14%) than in elderly men (7%). These results are consistent
with previous reports showing a higher prevalence of
ischemic ECG [20] and cardiovascular disease [30] in
elderly women than in elderly men. Taken together, these
data on the high prevalence of metabolic syndrome in
Table 6. Adjusted odds ratios (95% confidence interval)
for each component of metabolic syndrome and ischemic
ECG according to sex and age, as determined by multiple
logistic regression analysis
Age groups Men Women
Age 20 to 39 yr
Elevated glucose 1.95a (1.19 - 3.21) 2.49b (1.21 - 5.11)
Elevated BP 1.47 (0.89 - 2.41) 1.59 (0.55 - 4.64)
Elevated TG 1.25 (0.75 - 2.08) 0.44 (0.10 - 1.95)
Low HDL 1.25 (0.66 - 2.40) 1.83 (0.94 - 3.56)
Central obesity 2.19a (1.32 - 3.64) 0.67 (0.23 - 1.94)
Age 40 to 59 yr
Elevated glucose 1.17 (0.97 - 1.43) 1.21 (0.96 - 1.52)
Elevated BP 2.02a (1.67 - 2.45) 2.53a (2.05 - 3.14)
Elevated TG 1.05 (0.86 - 1.28) 1.28 (0.99 - 1.67)
Low HDL 1.26 (0.96 - 1.64) 1.03 (0.79 - 1.34)
Central obesity 2.02a (1.66 - 2.46) 1.36a (1.09 - 1.72)
Age ≥ 60 yr
Elevated glucose 1.42b (1.02 - 1.98) 1.59a (1.18 - 2.13)
Elevated BP 2.07a (1.43 - 3.01) 1.51b (1.09 - 2.08)
Elevated TG 0.91 (0.64 - 1.30) 1.02 (0.73 - 1.42)
Low HDL 1.77b (1.16 - 2.71) 0.99 (0.70 - 1.40)
Central obesity  1.43b (1.01 - 1.98) 1.33 (0.98 - 1.80)
ECG, electrocardiogram; BP, blood pressure; TG, triglyceride;
HDL, high-density lipoprotein cholesterol.
ap < 0.01.
bp < 0.05.Kim HK, et al. Metabolic syndrome and ECG abnormalities    179
elderly women reflect the higher risk of cardiovascular
disease in this group. 
Our study had several limitations. First, the study was
based only on resting ECG findings, not on clinically
symptomatic or angiographically documented coronary
artery disease. Baseline ECG abnormalities, however,
were found to be significantly associated with subsequent
coronary artery disease [11,12,31]. In addition, the low
cost, wide availability, and ease of interpretation makes
ECG a useful tool in large population studies. The second
limitation of our study was that our study subjects were
not a random sample of the general population; however,
the subjects we assessed may be representative of a
modernized urban population increasingly encountered in
developed or developing countries, and the large sample
size may reduce any potential selection bias. Third, our
analysis was cross-sectional, not longitudinal, suggesting
a need for additional follow-up to confirm the causal
relationship between metabolic syndrome and CVD. It
would also be useful to investigate the role of metabolic
syndrome in the prediction of cardiovascular event by a
follow-up ECG study. Despite these limitations, our results
indicate that identification of metabolic syndrome is an
important and useful clinical tool for screening subjects
with high cardiovascular risks, which can lead to increased
efforts to maintain a healthy lifestyle. Thorough evaluation
for latent CVD and careful follow up would also be
warranted for subjects with metabolic syndrome and ECG
abnormalities. 
In conclusion, these results show that metabolic
syndrome is strongly associated with ECG abnormalities,
especially ischemic ECG findings, in a Korean population;
however, the relationship between each component of
metabolic syndrome with ischemic ECG changes varied
according to age and sex. Further studies are required to
redefine the criteria for hypertriglyceridemia and central
obesity in Asian populations.
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